Can the Fenestrated Anaconda™ salvage failed competitor endografts? An international frame of reference

Matti Jubouri, Abdelaziz O Surkhi, Sven Z C P Tan, Damian M Bailey, Ian M Williams, Mohamad Bashir*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Downloads (Pure)


An abdominal aortic aneurysm (AAA) is a life-threatening abnormal dilation of the abdominal aorta that can be repaired either endovascularly or with open surgery. However, endovascular aortic repair (EVAR) has become the main treatment modality for AAA due to its more optimal results. EVAR devices can either be standard, fenestrated, or branched, with fenestrated EVAR (FEVAR) seemingly achieving superior prospects. Although EVAR is associated with excellent outcomes, it still carries a risk of certain complications requiring reintervention or 'rescue'. Several commercial EVAR devices are available on the global market, nevertheless, the Fenestrated Anaconda developed by Terumo Aortic can be considered the superior device due to the wide range of endovascular solutions that it offers along with its unique custom-made approach, excellent results and its highly promising potential to be used as a 'rescue' device for failed competitor endografts. The current study represents a 9-year cross-sectional international analysis of a custom-made Fenestrated Anaconda™ device. For the statistical analysis, SPSS 28 for Windows and R were utilised. Pearson Chi-square analysis was used to assess differences in cumulative distribution frequencies between select variables. Statistical significance for all two-tailed tests was set at < 0.05. Out of 5058 EVARs performed using the Fenestrated Anaconda, 2987 (59%) were 'rescue' procedures for migrated Gore (  = 252) and Medtronic (  = 2735) devices. The Fenestrated Anaconda™ was indicated as the reintervention device either due to unsuitable/complex anatomy for the competitor (  = 2411) or based on surgeon preference (  = 576). Overall, the Fenestrated Anaconda was utilised to rescue 3466 (68.5%) failed previous EVARs using competitor devices. Yet, the primary endovascular solution offered by the Fenestrated Anaconda was FEVAR (91.3%), with 112 (2.2%) devices using custom-made iliac stents. The use of the Fenestrated Anaconda endograft as a 'rescue' device to salvage failed competitor devices is well-established in the literature with excellent clinical outcomes achieved. The evidence in the literature also highlights the distinctive custom-made approach that the Fenestrated Anaconda offers which enables it to treat extremely complex aortic anatomy.
Original languageEnglish
Pages (from-to)582-588
Number of pages7
JournalAsian Cardiovascular and Thoracic Annals
Issue number7
Early online date13 Nov 2022
Publication statusE-pub ahead of print - 13 Nov 2022


  • aneurysm
  • anaconda
  • endovascular aortic repair
  • Abdominal aortic aneurysm
  • custom-made
  • fenestrated


Dive into the research topics of 'Can the Fenestrated Anaconda™ salvage failed competitor endografts? An international frame of reference'. Together they form a unique fingerprint.

Cite this